# Strategic Plan for Neutral Atom Quantum Computation

Preprint · Adrian J. Menssen, Tout Wang, Michael Gullans, Tom Manovitz, Jacob M. Taylor, Jason Cong, Josiah Sinclair, Ziv Aqua, Daniel J. Blumenthal, J. Pablo Bonilla Ataides, Johannes Borregaard, Antoine Browaeys, Paola Cappellaro, Soonwon Choi, Alexandre Cooper, Robin Côté, Jacob P. Covey, Alexandre Dauphin, Ivana Dimitrova, Matt Eichenfield, Dirk Englund, Jacob Freedman, Akihisa Goban, Brandon Grinkemeyer, Andi Gu and 31 more

- Archive id: arxiv:2607.21554
- Published: 2026-07-23
- arXiv: https://arxiv.org/abs/2607.21554
- Source URL: https://arxiv.org/abs/2607.21554
- PDF: https://arxiv.org/pdf/2607.21554
- Provenance: arxiv

## Abstract

We present a strategic plan for neutral atom quantum computation, bringing together hardware development and theory advancements to achieve the goal of practical quantum advantage. The concept of practical quantum advantage is defined, along with how to verify claims of advantage, and approaches to designing quantum algorithms that deliver practical advantage. Future directions for neutral atom quantum processor hardware are described: scaling-up system size, Qubit encodings and atomic platforms, going further below threshold with neutral-atom logical-qubit performance, continuous reloading of qubits, and fast readout. We also explore opportunities for scalable integrated photonic control technologies. Alongside hardware advancements, new developments in quantum error correction and compilation of quantum circuits are proposed. Finally, we examine the opportunity of networking multiple neutral atom quantum processors together to perform distributed quantum computing and overcome possible limitations of a single system.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
